Modified peptide nucleic acid compositions
US11603530B2 · kind B2 · utility
0Cited by
3References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 15, 2021 |
| Grant date | Mar 14, 2023 |
| Priority date | — |
| Expiry date | Apr 15, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to compounds useful for the detection or modulation of target nucleic acids, including DNA and RNA. The present disclosure further relates to methods for treatment of trinucleotide repeat disorders, which can include administration of oligonucleotide analogues that can bind pathogenic nucleotide repeats in DNA or RNA.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.